A Phase I/II Study of AZD0305 for Relapsed/Refractory Multiple Myeloma

Conditions: Multiple Myeloma Interventions: Drug: AZD0305 Sponsors: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials